- $4.08bn
- $3.97bn
- $718.56m
- 99
- 13
- 48
- 53
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 596 | 592 | 553 | 646 | 719 |
Cost of Revenue | |||||
Gross Profit | 125 | 126 | 124 | 152 | 158 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 534 | 532 | 493 | 562 | 634 |
Operating Profit | 61.5 | 60.7 | 59.2 | 84.5 | 84.6 |
Net Income Before Taxes | 61.5 | 60.7 | 59.2 | 84.5 | 84.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 46.1 | 47.4 | 46.4 | 66.4 | 66.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 46.7 | 47.4 | 46.4 | 66.4 | 66.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 46.7 | 47.4 | 46.4 | 66.4 | 66.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.43 | 2.55 | 2.55 | 3.66 | 3.77 |